This week saw both Regenxbio and Solid Bio report new data with their gene therapy candidates for Duchenne muscular dystrophy ...
Hans Schambe joins BOOST Pharma – a clinical-stage biopharmaceutical company developing novel off-the-shelf cell therapies for rare paediatric skeletal diseases – from Galecto Inc., where as president ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results